³ÉÈËVRÊÓƵ

Kenneth Myers

Academic title(s): 

Assistant ProfessorÌý

MD, PhD, FRCPC, CSCN (EEG)Ìý

Kenneth Myers
Contact Information
Address: 

Montreal Children’s Hospital
1001 Decarie Boulevard
Montreal, Quebec, H4A 3J1

Email address: 
kenneth.myers [at] mcgill.ca
Division: 
Neurology
Area(s): 
Clinical trials
Degree(s): 
  • BSc Hon, Physics & Physiology, Simon Fraser University, 1998-2003
  • MD-PhD, Biomedical Engineering, University of Calgary, 2004-2010
  • Residency in Pediatric Neurology, University of Calgary, 2010-2015
  • Fellowship in Epilepsy, University of Melbourne, 2015-2017
Biography: 

Dr. Kenneth Myers grew up in Kingston, Ontario, and after high school moved to British Columbia where he completed an honours BSc in Physics & Physiology. In 2004, Dr. Myers went to Alberta and completed a PhD in Biomedical Engineering, an MD, and then a residency in Pediatric Neurology, all at the University of Calgary. In 2015, he moved to Melbourne, Australia for a 2-year fellowship in epilepsy with an emphasis on genetics, under the supervision of Professors Ingrid Scheffer and Sam Berkovic. Dr. Myers started at the Montreal Children’s Hospital in 2017 in a clinician-researcher role – his research is mainly directed at better understanding genetic causes of epilepsy, and includes clinical trials for rare diseases. He has loved his time in Montreal thus far, in particular the collegial and intellectually-stimulating atmosphere in the MUHC. Outside of work, he enjoys running, cross-country skiing, and playing with his dog.

Areas of expertise: 
  • EpilepsyÌý
  • GeneticsÌý
  • Clinical trialsÌý
Areas of interest: 
  • Clinical trials for rare neurologic diseasesÌý
  • Genetic causes of epilepsyÌý
  • Sudden unexpected death in epilepsyÌý
  • Autonomic dysfunction in people with epilepsyÌý
Awards, honours, and fellowships: 
  • Citizens United for Research in Epilepsy, Taking Flight Award, 2016
  • Canadian League Against Epilepsy, Junior Investigator Award, 2021
  • Fonds de recherche de Québec – Santé, Junior 1 Chercheur-Boursier Clinicien, 2020-2024
Back to top